Design Therapeutics Inc (DSGN)
5.33
-0.09
(-1.66%)
USD |
NASDAQ |
Sep 27, 16:00
5.35
+0.02
(+0.38%)
After-Hours: 20:00
Design Therapeutics Free Cash Flow: -51.47M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -51.47M |
| March 31, 2024 | -53.94M |
| December 31, 2023 | -58.82M |
| September 30, 2023 | -61.37M |
| June 30, 2023 | -60.99M |
| March 31, 2023 | -57.84M |
| December 31, 2022 | -52.24M |
| September 30, 2022 | -46.44M |
| Date | Value |
|---|---|
| June 30, 2022 | -41.36M |
| March 31, 2022 | -39.09M |
| December 31, 2021 | -30.92M |
| September 30, 2021 | -24.19M |
| June 30, 2021 | -16.98M |
| March 31, 2021 | -9.707M |
| December 31, 2020 | -8.669M |
Free Cash Flow Range, Past 5 Years
-61.37M
Minimum
Sep 2023
-8.669M
Maximum
Dec 2020
-40.93M
Average
-46.44M
Median
Sep 2022
Free Cash Flow Benchmarks
| Biogen Inc | 1.468B |
| PTC Therapeutics Inc | -230.14M |
| Voyager Therapeutics Inc | -22.27M |
| NovaBay Pharmaceuticals Inc | -3.396M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.26M |
| Cash from Investing (Quarterly) | 27.33M |
| Cash from Financing (Quarterly) | 0.229M |
| Free Cash Flow Per Share (Quarterly) | -0.2019 |
| Free Cash Flow Yield | -17.16% |